DSC Advisors’s CVS Health CVS Stock Holding History

DSC Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-56,700	Closed	-$4.73M	–	73
2021 Q2	$4.73M	Buy	+56,700	New	+$4.64M	3.42%	8
2018 Q4	–	Sell	-100,000	Closed	-$7.87M	–	74
2018 Q3	$7.87M	Buy	+100,000	New	+$7.15M	1.06%	16
2016 Q3	–	Sell	-44,000	Closed	-$242K	–	68
2016 Q2	$242K	Buy	+44,000	New	+$4.39M	0.15%	43
2015 Q4	–	Sell	-100,000	Closed	-$433K	–	66
2015 Q3	$433K	Buy	+100,000	New	+$10.5M	0.21%	51

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

DSC Advisors's CVS Position: Q3 2024 in Review

DSC Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 100,229 shares — an estimated $5.92M sold.

DSC Advisors first reported a position in CVS in Q2 2013 and held it in 42 quarters. The position peaked at $22.8M in Q2 2015. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

DSC Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
DSC Advisors sold 100,229 CVS Health shares in Q3 2024, an estimated $5.92M.
DSC Advisors first reported a position in CVS Health in Q2 2013 and held it in 42 quarters.
DSC Advisors's CVS Health position peaked at $22.8M in Q2 2015.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on DSC Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.